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MAJOR ARTICLE

Distribution of Kaposi Sarcoma–Associated
Herpesvirus/Human Herpesvirus 8 in Maternal
Saliva and Breast Milk in Zambia:
Implications for Transmission
Brad P. Brayfield,1 Chipepo Kankasa,4,5 John T. West,1 Jubra Muyanga,4,5 Ganapati Bhat,4,5 Winslow Klaskala,1,3
Charles D. Mitchell,2 and Charles Wood1
1

Nebraska Center for Virology and School of Biological Sciences, University of Nebraska, Lincoln; 2Department of Pediatrics, University
of Miami School of Medicine, Miami, Florida; 3Roche Laboratories, Nutley, New Jersey; 4Department of Pediatrics, University
of Zambia School of Medicine, and 5University Teaching Hospital, Lusaka, Zambia

Background. The seroprevalence of Kaposi sarcoma–associated herpesvirus (KSHV)/human herpesvirus 8
(HHV-8) in sub-Saharan Africa suggests that multiple routes of transmission exist. In the present study, we examined
2 possible routes of mother-to-child transmission, through breast milk and saliva, during the first 6 months after
delivery.
Methods. The prevalence of HHV-8 DNA in the breast-milk cells (n p 75 ), milk supernatant (n p 56),
colostrum (n p 2), and saliva cells (n p 65 ) of HHV-8–seropositive mothers who recently gave birth was examined.
Polymerase chain reaction analysis was performed for the detection of HHV-8 in cross-sectional samples isolated
at 2, 4, and 6 months after delivery.
Results. None of the 75 breast-milk samples but 2 of the colostrum samples that were analyzed contained
HHV-8 DNA at a limit of detection of ∼1 HHV-8 copy/10 4 cellular genomes, whereas Epstein-Barr virus DNA
and HIV-1 DNA were detected in 16 and 22 samples, respectively. Analysis of 65 saliva cell samples, which were
obtained from mothers who also provided milk samples, revealed that 19 of the samples had detectable HHV-8
DNA. Viral DNA was found at all time points, but the presence of viral DNA in saliva was independent of maternal
HIV-1 serostatus (x 2 p 0.33; P p .57).
Conclusions. Our findings demonstrate the lack of HHV-8 DNA in the breast milk of seropositive mothers,
and they suggest that contact with breast milk is not a likely source of horizontal transmission of virus to infants
in sub-Saharan Africa.
Human herpesvirus 8 (HHV-8) was first identified, in
1994, in tissue from a patient with AIDS who had Kaposi sarcoma (KS) [1]. In the United States and Western
Europe, HHV-8 infection is uncommon in the general population, but it is considered to be common in
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regions of South America, southern Italy, and Africa
[2–4]. After the onset of the AIDS pandemic, several
sub-Saharan countries, including Zambia, reported a
significant increase in the number of cases of KS among
both adults and children [5, 6]. In the United States
and Western Europe, similar increases in KS were observed, but these increases were observed almost exclusively among HIV-1–infected men. This suggests
that different routes of transmission of HHV-8 or different rates of infection may be occurring in these populations, or that different genetic, cultural, or environmental factors influence transmission of HHV-8.
The modes of transmission of HHV-8 remain poorly
understood, despite the existence of significant data on
virus seroprevalence. In areas in which seroprevalence
is low, HHV-8 appears to be predominantly acquired
through sexual contact. Infection and seroconversion

have been associated with male homosexual practices and the
number of HIV-1–positive sex partners, and they also have been
associated with individuals at risk for STD [7–9]. In the United
States, saliva has been implicated as a source for transmission of
HHV-8, because viral DNA has been detected in as many as 70%
of oral cavity samples in studies involving HIV-1–infected men
with KS [10]. Very little is known regarding the presence of HHV8 in saliva and the mechanisms of transmission of HHV-8 in
regions of endemicity. A cumulative increase in the seroprevalence of HHV-8 in children, from birth through adolescence, has
been observed in regions of endemicity; this finding suggests that
multiple routes, including perinatal transmission, are involved
[4, 11]. Perinatal transmission of HHV-8 may occur as a result
of breast-feeding, as has been previously suggested for cytomegalovirus (CMV) [12], but it fails to account for the continued
acquisition of HHV-8 after breast-feeding has ceased. CMV, as
well as other herpesviruses, has been detected in milk and predominantly localizes to the breast-milk supernatant (liquid) fraction [13]. Whether HHV-8 can be detected in breast milk from
infected mothers is not known.
We previously documented HHV-8 infection that occurred
in Zambian children by 12 months of age, using serological
and HHV-8 DNA detection methods [14, 15]. Although children born to HHV-8–infected mothers can be congenitally infected, the frequency of such transmission is apparently low
and does not adequately account for the increasing seroprevalence subsequent to gestation and delivery [4, 11, 15]. Therefore, horizontal transmission is a likely route for a large proportion of HHV-8 infections that occur in early childhood.
As part of our continuing cohort study of the epidemiology
of HHV-8 infection among Zambian mother-infant pairs, the
major goal of the present study was to examine whether transmission of HHV-8 to infants can occur via breast milk. In the
present study, we determined the prevalence of virus in breast
milk and maternal saliva. Establishing the presence or absence
of HHV-8 in these maternal body fluids will extend our understanding of how HHV-8 is spread to children and will
thereby enable the development of strategies to prevent transmission of HHV-8 and pediatric KS.

SUBJECTS, MATERIALS, AND METHODS
Subjects and specimen collection. Analyses were performed
for specimens obtained from participants in a longitudinal cohort study of transmission of HHV-8 performed at the University of Zambia Teaching Hospital (UTH; Lusaka, Zambia).
Approval for the study was obtained from the Ministry of
Health of Zambia, the Research and Ethics Committee of the
UTH, and the institutional review boards of the University of
Nebraska–Lincoln and the University of Miami (Miami, FL).
Written, informed consent was obtained from all study partic-

ipants. In the present study, mothers who showed no clinical
signs of KS were recruited, at delivery, in the labor ward of the
UTH, and they were followed through the first 6 months after
delivery. Whole breast-milk and saliva samples were obtained
and were spun for 10 min at 500 g, to separate the liquid and
cell portions; each sample was stored at ⫺80C.
Extraction of DNA from breast milk and saliva. Extraction of thawed cell pellets was performed using the Gentra
Systems DNA isolation kit with proteinase K (0.1 mg/mL),
according to the manufacturer’s instructions [14]. For extraction of viral DNA from the liquid portion of breast milk, samples were spun for 5 min at 10,000 g, and 150 mL of supernatant
was decanted and used for viral DNA extraction, which was
performed as described above. All DNA extractions were segregated from polymerase chain reaction (PCR) amplification
and plasmid manipulation and were performed in a dedicated
laboratory, with the use of an isolated hood with UV light;
stringent conditions and controls were used to minimize contamination between samples.
Conventional HHV-8, Epstein-Barr virus (EBV), and HIV1 PCR. DNA extracted from the samples was subjected to
PCR specific for human b-globin, by use of primers described
elsewhere [16]. The b-globin PCR–positive samples were subsequently analyzed for HHV-8 by use of primers for the minor
capsid (ORF26) and gB (N-terminus [gBN]) genes, as described
elsewhere [1, 15, 17]. Samples were defined as being positive
for HHV-8, either by first-round PCR for both ORF26 and gB,
with confirmation by Southern blot analysis, or by nested PCR
that consistently detected positive samples by both ORF26 and
gBN PCR performed in 2 separate amplification reactions. PCR
analysis for EBV was performed using primers specific for the
EBV thymidine kinase (TK) gene: TK1 (5-GTGGGATCCATGGCTGGATT-3) and TK2 (5-GCTACCCGGAGAGTTTCCAGT-3). Thermal-cycling parameters for EBV-TK PCR were
as follows: 1 cycle for 5 min at 95C; 38 cycles for 30 s at 95C,
for 30 s at 56C, and for 30 s at 72C; and 1 cycle for 3 min
at 72C. All reactions were subjected to Southern blot analysis
by use of a digoxigenin-labeled probe, as described elsewhere
[15]. HIV-1 PCR was used to detect a short sequence of the
5 viral long-terminal repeat in all breast-milk samples obtained
from HIV-1–infected mothers, as described elsewhere [18].
Real-time PCR for the detection of HHV-8. Real-time
PCR for the detection of HHV-8 and human b-globin was used
for all samples demonstrated to be positive by conventional
PCR, to quantitate the number of copies of HHV-8 and the
number of cellular equivalents present in each sample [16, 19].
For the present study, real-time PCR was performed according
to the manufacturer’s suggested conditions, by use of TaqMan
chemistry (Applied Biosystems). The HHV-8 reaction, which
used an amplicon within the ORF73 gene, contained 300 nmol/
L forward primer (lat-273F), 200 nmol/L reverse primer (latKSHV DNA in Saliva and Breast Milk • JID 2004:189 (15 June) • 2261

Figure 1. Detection of human herpesvirus 8 (HHV-8) in breast milk
and saliva, by use of conventional and TaqMan-based polymerase chain
reaction (PCR). A, First-round ORF26 PCR and human b-globin–specific
PCR were performed on BCBL-1 DNA (10–105 HHV-8 copies, as determined
by real-time PCR) and on spiked donor breast-milk (top) and saliva
(bottom) DNA samples, to determine the sensitivity of detection of HHV8 in each body fluid. Donor DNA alone (0) and DNA from the EpsteinBarr virus–positive, HHV-8–negative Burkitt lymphoma cell line (Jijoye
[JJ]), were run in parallel as controls. B, Representative experiments of
first-round ORF26 PCR and human b-globin–specific PCR performed on
DNA in breast-milk (top) and saliva cell (bottom) samples obtained from
6 patients (1–6), with BC-3 DNA used as a positive control. C, Standard
curve for real-time PCR for HHV-8. The standard curve used for determination of the HHV-8 copy number, generated from 5 independent experiments and 15 replicates, is shown. The standards, as log input of
HHV-8 copies, are plotted versus the mean cycle threshold, with error
bars representing 2 times the SEM. An r 2 of 0.993 indicates a strong
linear relationship between input copies and the cycle threshold.
2262 • JID 2004:189 (15 June) • Brayfield et al.

335R), and 200 nmol/L dual-labeled TaqMan probe (lat-294T).
The standard curve for HHV-8 was generated using a cloned
sequence of the ORF73 gene in the pGEM-T vector as template
(pGEMT.lat294T), according to the manufacturer’s instructions
(Promega). Purified pGEMT.lat294T was linearized by restriction enzyme digestion, and the copy number was calculated
from the determination of molecular mass. Serial 10-fold dilutions (10–10 5-fold dilutions) of the plasmid were made in a
background of 10 4 human genomes/mL (derived from unstimulated peripheral blood mononuclear cells [PBMCs]). A similar
standard curve was generated for human b-globin PCR by
diluting known copies of unstimulated PBMC DNA in TrisEDTA buffer. PBMC DNA copy numbers were generated by
quantifying the amount of PBMC DNA by use of a spectrophotometer and by multiplying this amount by a conversion
factor between the number of genomic copies and the molecular weight (1.2 ⫻ 10 5 genomic copies/mg DNA). By use of
BioRad iCycler software (version 3.0b; BioRad Laboratories),
the cycle threshold (CT) from the PCR amplification of the
HHV-8 and b-globin standards was used to generate a curve
for each amplicon (r 2 1 0.98), allowing for accurate extrapolation of HHV-8 and b-globin copy numbers present in the
known samples. For each reaction, the standard curve for HHV8 and a similar standard curve for the human b-globin gene
were run in parallel with saliva samples. Samples were run in
triplicate, and the average CT value was calculated and used
for determination of the copy number.
Sequence and phylogenetic analysis of HHV-8 K1. PCR
amplification of the K1 gene was performed on HHV-8–positive
saliva samples, as well as the HHV-8 persistently infected BC3 and BCBL-1 cell lines, by use of several primer sets. For firstround PCR amplification of K1, primers 2089 and 2088 were
used as described elsewhere [20]. Nested PCR was performed
on HHV-8–negative samples by use of primers K1A (5-GGTTTGCTTTCGAGGACTATTA-3; nt 134–155) and K1D (5CAGAGCTACGAGTGTCATAAATA-3; nt 796–818), both of
which were based on the BC-1 genomic sequence. HHV-8–
negative samples were further subjected to alternative PCR that
used primers K1A and K1B (5-GCTGACCACAAGTGACTGTGTT-3; nt 417–438). K1A/D or K1A/B PCR fragments
were amplified, and products were gel purified and cloned into
pGEM-T vector, according to the manufacturer’s recommendations (Promega). Stringent conditions were used to limit PCR
contamination, as outlined in the “Conventional HHV-8, Epstein-Barr virus (EBV), and HIV-1 PCR” subsection above, and
equivalently amplified BC-3 or BCBL-1 sequences were cloned
and sequenced in parallel to serve as controls. Two colonies
were sequenced using the ABI BigDye Terminator Cycle Sequencing Ready Reaction Kit and the ABI 373 DNA Sequencer
(Applied Biosystems), according to the manufacturer’s specified procedures. Sequences were aligned manually by use of

Table 1. Detection of human herpesvirus 8 (HHV-8), Epstein-Barr virus (EBV), and HIV-1, by polymerase
chain reaction (PCR) analysis of cross-sectional breast-milk cell samples obtained from HHV-8–seropositive
(HHV-8+) mothers during the first 6 months after delivery.
HHV-8

+

HIV-1

Months
after delivery

Months
after delivery

Months
after delivery

+

HHV-8 group
(HIV-1 serostatus)

EBV

Total

2

4

6

Total

2
a

4

6

Total

2

4

6

1 (HIV-1 )

0/33

0/24

0/9

nt

15/33

8/24

7/9

nt

22/33

18/24

4/9

nt

2 (HIV-1⫺)

0/42

0/24

0/12

0/6

1/42

0/24

0/12

1/6

nt

nt

nt

nt

0/75b,c

0/48

0/21

0/6

16/75

8/48

7/21

1/6

22/33

18/24

4/9

nt

Total
NOTE.

Data are no. of positive samples/no. of samples tested. HIV-1+, HIV-1 positive; HIV-1⫺, HIV-1 negative; nt, none tested.

a

x2 p 20.4; P ! .001.
b
Does not include the 2 ORF26 PCR–negative colostrum samples obtained from HHV-8+ women.
c
Five specimens were found to be positive once, by use of nested ORF26 PCR, but positive status could not be confirmed
by PCR performed with a second set of primers.

CLUSTAL W [21], and neighbor-joining trees were constructed
using general time reversible distance with phylogenetic analysis
using parsimony (PAUP, version 4.0 b10; Sinauer Associates).
Statistical analysis. x 2 Tests for independence were performed for analysis of PCR detection between populations. The
Wilcoxon rank sum test was used for comparisons of the median number of HHV-8 copies.
RESULTS
Detection of HHV-8 copy standards in breast milk and saliva.
To examine the horizontal transmission of HHV-8 from mother
to infant via breast milk and/or saliva in Zambia, we first determined the sensitivity of PCR performed on both body fluids.
BCBL-1 DNA with known HHV-8 copy numbers, as determined by real-time PCR, was added to equivalent amounts of
donor DNA, and the limit of detection in breast milk and saliva
was determined by PCR amplification of the ORF26 gene. DNA
extracted from donor milk and saliva samples, at a concentration of 100 ng/mL (∼10 4 cellular genomes/mL), was then used
to serially dilute BCBL-1 DNA in 10-fold increments, creating
HHV-8 copy standards from 1 to 10 5 viral copies. By use of
the viral copy standards, HHV-8 DNA was consistently detected
using conventional PCR with first-round ORF26 primers at 1
viral copy in a background of 10 4 milk cell equivalents and at
10 viral copies in 10 4 saliva cell equivalents (figure 1A). In donor saliva DNA, a faint band was observed with the 1-copy
standard, but detection was inconsistent. In addition, HHV-8
PCR could detect the presence of 10 BC-3 cells in whole milk,
by use of the same extraction and PCR conditions (data not
shown). No PCR product was amplified, under the same conditions, by use of DNA extracted from a related herpesvirus
(i.e., EBV)–infected cell line, Jijoye (figure 1A).
Prevalence of HHV-8 in breast milk. Although HHV-8
has been detected in a variety of tissues and body fluids from
infected persons, the presence of HHV-8 in breast milk has

remained unexamined. The cross-sectional prevalence of HHV8 in breast milk from seropositive mothers in Zambia was determined. HHV-8–infected patients were divided into 2 groups:
HIV-1–seropositive patients (group 1) and HIV-1–seronegative
patients (group 2), as defined elsewhere [14]. DNA extracted
from fresh colostrum and frozen breast-milk cell pellets obtained close to the time of birth (for colostrum) or at 2, 4, or
6 months after delivery (for breast milk) was first analyzed for
DNA integrity and for the presence of inhibitors, by use of
human b-globin primers. Only b-globin–positive samples were
used for subsequent detection of HHV-8. PCR analysis of 2
colostrum samples, as well as 33 and 42 breast-milk samples
from HIV-1–infected mothers and uninfected mothers, respectively, failed to consistently detect HHV-8 DNA in any
sample (table 1). Five milk specimens were sporadically determined to be positive for HHV-8 DNA when they were assayed
with nested ORF26 primers, but detection was inconsistent and
could not be confirmed using primers from either the gB gene
or the K1 gene. Thus, given the sensitivity of the assay (1 copy/
10 4 cells), these specimens were considered to be negative for
Table 2. Detection of human herpesvirus 8 (HHV-8) and EpsteinBarr virus (EBV) by polymerase chain reaction analysis of crosssectional breast-milk supernatant samples obtained from HHV8–seropositive (HHV-8+) mothers during the first 6 months after
delivery.
EBV

HHV-8

+

HHV-8 group
(HIV-1 serostatus) Total
+

Months
after delivery
2

4

6

Months
after delivery
Total
a

2

4

6

1 (HIV-1 )

0/22 0/14 0/7

0/1

7/22

4/14 3/7

2 (HIV-1⫺)

0/34 0/18 0/10 0/6

0/34

0/18 0/10 0/6

0/1

Total

0/56 0/32 0/17 0/7

7/56

4/32 3/17 0/7

NOTE. Data are the no. of positive samples/no. of samples tested. HIV1+, HIV-1 positive; HIV-1⫺, HIV-1 negative.
a

x2 p 12.4; P ! .001.
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Table 3.
Detection of human herpesvirus 8
(HHV-8) by polymerase chain reaction analysis of
cross-sectional saliva cell samples obtained from
HHV-8–seropositive (HHV-8+) mothers during the
first 6 months after delivery.
Months
after delivery

HHV-8+ group
(HIV-1 serostatus)

Total

2
a

+

4

6

1 (HIV-1 )

6/24

4/15

2/8

0/1

2 (HIV-1⫺)

13/41

6/21

3/12

4/8

Total

b
19 /65

10/36

5/20

4/9

NOTE. Data are no. of positive samples/no. of samples
tested. HIV-1+, HIV-1 positive; HIV-1⫺, HIV-1 negative.
a
b

x2 p 0.13; P p .71.
Twenty-nine percent of samples.

HHV-8. Results of a representative experiment performed with
6 breast-milk samples obtained from HHV-8–seropositive
mothers are shown in figure 1B. The same breast-milk samples
were also subjected to PCR specific for EBV, which is known
to be present in breast milk [13], to ensure that herpesvirus
DNA could be amplified in the present analysis. EBV was detected in 16 of 75 breast-milk cell samples, with the presence
of EBV dependent on the HIV-1–positive serostatus of the
mother, as shown in table 1. Furthermore, PCR amplification
of a small fragment of the HIV-1 LTR revealed that 22 of 33
breast-milk samples obtained from patients in group 1 contained HIV-1 DNA (table 1). To determine whether HHV-8
was present in the liquid portion of breast milk, DNA was
extracted from the supernatant fractions prepared from whole
milk. Fifty-six cognate supernatant samples were available from
the breast-milk cell samples analyzed and reported in table 1.
None of these samples was found to be positive for HHV-8 by
ORF26 PCR, by use of both first-round and nested ORF26 PCR
reactions, a finding that is similar to what was observed for
the cellular fraction (table 2). On the other hand, EBV-specific
PCR revealed 7 positive samples.
Prevalence of HHV-8 in saliva. Because HHV-8 was un-

detectable in breast-milk cells from HHV-8–seropositive mothers, and because breast milk is unlikely to be a source of transmission of HHV-8 to infants, we next examined the prevalence
of HHV-8 in cross-sectional saliva cell samples obtained from
the same population of seropositive mothers. For DNA from
maternal saliva cells obtained at 2, 4, or 6 months after delivery,
PCR analysis was performed using the same criteria for positive
samples that were mentioned above for breast-milk analysis.
Table 3 shows the results of HHV-8 PCR analysis of saliva cell
samples obtained from 65 HHV-8–seropositive mothers. The
saliva cell samples of 19 mothers were positive for HHV-8 DNA,
with positive results noted for 10, 5, and 4 samples obtained
at 2, 4, and 6 months, respectively. Furthermore, the probability
of a mother having a saliva cell sample that was positive at a
single time point was independent of the HIV-1 serostatus of
the mother (patients in group 1 vs. patients in group 2; x2 p
0.33; P p .57). A representative experiment of ORF26 PCR
performed on saliva samples obtained from the same 6 mothers
who had breast-milk samples analyzed for HHV-8 in figure 1A
is shown in figure 1B. To determine whether mothers whose
breast-milk samples were negative for HHV-8 had detectable
viral DNA in saliva cells, mothers with breast-milk and saliva
cell samples obtained at the same follow-up visit had their
samples analyzed. A total of 60 mothers with paired specimens
were compared with respect to HHV-8 PCR status. At each
follow-up time point, HHV-8 was detected in saliva samples,
but not in breast-milk samples, obtained from the same patient
(table 4).
The HHV-8 infection status of the infants of a subset of the
mothers whose saliva samples were analyzed for the presence
of HHV-8 (n p 55) was then determined at 12 months after
delivery. To eliminate the detection of maternal antibodies, the
antibody titers of the infants were determined, at different time
points after delivery, by use of lytic IFA analysis, as performed
elsewhere [14]. Twelve infants had antibody titers determined
at birth and at 6 months after delivery, whereas 43 infants had
antibody titers determined at birth and at 12 months after

Table 4. Results of human herpesvirus 8 (HHV-8) polymerase chain reaction analysis
performed on paired breast-milk and saliva cell samples obtained from HHV-8–seropositive (HHV-8+) mothers at different time points after delivery.
Months after delivery
HHV-8+ group
a
(HIV-1 serostatus)

2

4

6

Breast milk

Saliva

Breast milk

Saliva

Breast milk

Saliva

1 (HIV-1 )

0/15

4/15

0/7

2/7

nt

nt

2 (HIV-1⫺)

0/20

6/20

0/12

3/12

0/6

3/6

Total

0/35

10/35

0/19

5/19

0/6

3/6

+

NOTE. Data are no. of positive samples/no. of samples tested. HIV-1+, HIV-1 positive; HIV-1⫺, HIV1 negative; nt, none tested.
a

N p 60.
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Figure 2. Real-time polymerase chain reaction (PCR) analysis of the 16 saliva cell samples obtained from 12 patients who were found to be
positive for human herpesvirus 8 (HHV-8) by conventional PCR. A, The nos. of human b-globin and HHV-8 copies were calculated per sample, and
the mean nos. of HHV-8 copies/104 cells analyzed are shown for triplicate reactions, with error bars representing the SD. Patients 5, 7, 10, and 12
had real-time PCR performed at 2 time points. The time points when the saliva specimens were obtained are indicated. B, Box-and-whisker plots of
the number of HHV-8 copies in saliva cell samples obtained from HIV-1–infected mothers and uninfected mothers. Minimum and maximum values
(), as well as the mean (—) and median (⫻) values, are shown. Black bars denote samples obtained at 2 months; gray bars, samples obtained at
4 months; and white bars, samples obtained at 6 months. The box denotes the range of values between the first and third quartiles. P p .26, 1sided Wilcoxon rank sum test of medians.

delivery; only infants who had increasing antibody titers from
birth to either 6 or 12 months of age were considered to be
infected. In the subset of 55 mother-infant pairs, 14 of the mothers were found to be positive for HHV-8 DNA in saliva, by PCR,
whereas 41 were found to be negative for HHV-8 by PCR. IFA
analysis revealed that 14 of 55 infants were seropositive for HHV8 by 12 months after delivery. Of these 14 seropositive infants,
3 were born to mothers who had detectable HHV-8 DNA in
their saliva cells, and 11 were born to mothers who had no HHV8 DNA in their saliva at the time that saliva cells were obtained.
The probability of an infant being seropositive for HHV-8 was
independent of the HHV-8 PCR status of their mother’s saliva,
as tested at 1 time point (x 2 p 0.16; P p .68).
Quantification of HHV-8 in saliva. Knowing that several
mothers in our study group had detectable HHV-8 in saliva,

we next sought to determine the number of copies of HHV-8
in saliva cells, by use of established real-time PCR procedures.
By use of plasmid copy-number standards from 10 to 10 5 copies
of the ORF73 gene/reaction, a high correlation was observed
between input plasmid copies and the CT value (r 2 p 0.993);
this finding indicates that detection of HHV-8 was linear over
4 orders of magnitude (figure 1C). By use of real-time PCR,
BCBL-1 and BC-3 cells were found to contain ∼26 and 13
HHV-8 copies/cell, respectively (data not shown). The relative
cellular and viral copy numbers/sample were determined, and
samples that contained 15000 cellular equivalents and ⭓10
copies of HHV-8 were reported as the number of HHV-8 copies/10 4 cellular equivalents. Insufficient quantity of several of
our saliva samples prevented analysis of all mothers found to
be positive for HHV-8 by conventional PCR. Sixteen samples
KSHV DNA in Saliva and Breast Milk • JID 2004:189 (15 June) • 2265

Figure 3. K1 amino acid alignment and phylogenetic analysis of saliva samples. A, Amino acid alignment of the first variable region of K1 (variable
region 1 [VR1]; aa 52–92) from BCBL-1, BC-3, and saliva samples from patients 1609 and 1166; 3 peripheral blood mononuclear cell samples obtained
from patients with KS in Zambia and analyzed in our laboratory (sequences 08M, 111I, 124I; unpublished data); and 46 other HHV-8 strains representing
clades A–D (obtained from GenBank). B, Phylogenetic tree of the VR1 nucleotide sequence (123 nucleotides) generated by neighbor joining with
phylogenetic analysis using parsimony (PAUP, version 4.0 b10; Sinauer Associates), for all samples in panel A, with the BC-1 sequence used as an
outgroup. Subtypes and variants are indicated to the right of each sequence. Arrows denote the 2 saliva samples from the present study. CAR, Central
African Republic; FG, French Guiana; NZ, New Zealand; UK, United Kingdom.

obtained from the 12 mothers who were found to be positive
for HHV-8 by conventional PCR (8 mothers with samples from
1 time point tested and 4 mothers with samples from 2 time
points tested) met the aforementioned criteria for quantitative
analysis. These samples are shown in figure 2A. A large variation
in the mean number of HHV-8 copies/10 4 cells was observed
(range, 4–1185 copies/10 4 cells). Of the mothers who had samples from 2 time points tested, 3 had samples that showed
variations between time points. Two mothers had samples with
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high copy numbers at one time point but very low copy numbers at the other time point, whereas 1 mother had only a small
difference between time points.
To test whether HIV-1 infection increases the HHV-8 burden
in saliva cells, the number of HHV-8 copies/10 4 cells was examined in both HIV-1–infected mothers and uninfected mothers (figure 2A) at all time points. The median, the mean, and
the first and third quartile ranges are shown in figure 2B, for
HIV-1–infected mothers and uninfected mothers. Mothers who

Figure 3.

(Continued.)

were infected with HIV-1 appeared to have a higher median
number of HHV-8 copies/104 cells, but the Wilcoxon rank sum
test of medians did not reveal a significant difference between
HIV-1–infected and uninfected mothers (P p .26 , by 1-sided
Wilcoxon rank sum test), on the basis of evaluation of a small
number of samples (n p 16).
Sequence analysis of the K1 gene of HHV-8–positive patients. The HHV-8 glycoprotein K1 has been shown to contain regions of high variability (variable region 1 [VR1] and
variable region 2 [VR2]), and these regions have been used to

segregate HHV-8 strains into distinct clades [22]. Because of
the high degree of variability present in the VR1, we used this
region to determine whether the HHV-8 sequences detected in
the saliva samples evaluated in the present study were related
to other known African isolates. In addition, we wanted to
exclude the possibility of PCR contamination by laboratory
BCBL-1 or BC-3 HHV-8 sequences. Figure 3A shows the amino
acid alignment of the VR1 of K1 (aa 52–92) for 2 saliva samples
that were found to be positive for HHV-8 (samples 1609 and
1166), consensus sequences from PBMC samples isolated from
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3 Zambian patients with KS analyzed at the University of Nebraska–Lincoln (sequences 08I, 124I, and 111M), and 43 other
published VR1 sequences comprising all clades and variants of
HHV-8 based on K1 [22–24]. The saliva sequences are distinct
from each other at 3 amino acid positions, and they differ from
the BCBL-1 and BC-3 sequences used in our laboratory. Furthermore, they show similarity to, but are distinct from, clade B
K1 sequences from Africa, including Ug52, UgD1, Mou, Ali, 431,
and G91, and the other Zambian sequences (sequences 08I, 124I,
and 111M ). Phylogenetic analysis of the VR1 nucleotide sequence from the same 2 saliva samples in the present study, along
with the same K1 sequences used in the amino acid alignment,
is shown in figure 3B. Similar to the amino acid alignment, the
neighbor-joining analysis indicates that the 2 saliva isolates recovered from Zambian mothers are closer to clade B African
sequences than to those from other geographic regions.

DISCUSSION
The seroprevalence of HHV-8 in several regions of the world
supports the concept that multiple factors influence transmission and that multiple modes of transmission may exist [9, 14,
25]. Our previous work on mother-to-infant transmission of
HHV-8 suggested that in utero or intrapartum transmission
was not a major contributor to the occurrence of HHV-8 infection in the first year of life [14, 15]. Continued work has
also shown that many infants have seroconversion to an HHV8–positive status during the first year after delivery; therefore,
the primary purpose of the present analysis was to determine
whether HHV-8 could be detected in maternal fluids with potential for virus transmission, such as breast milk and saliva.
A number of herpesviruses, including human herpesvirus 7,
EBV, CMV, and herpes simplex virus 1, have been detected in
breast milk, supporting the possibility of maternal-to-infant
transmission via this fluid [26–29]. Studies of infants who were
breast-fed by CMV-seropositive mothers have reported rates of
infection of 37%–76%, compared with 4% for infants breastfed by seronegative mothers [27, 30, 31]. CMV DNA was more
frequently detected in breast-fed infants than in bottle-fed infants [31, 32]. Moreover, 2 studies reported the absence of viral
DNA in the breast milk of CMV-seronegative mothers, with
the result that none of the infants of these mothers were infected
after birth [27]. Both CMV and HHV-8 are known to infect
monocytes, macrophages, and epithelial cells, both of which
are found in the cellular components of colostrum and mature
milk [33–36]. Thus, extrapolation of findings from studies of
CMV suggest that HHV-8 might also be found in breast milk
and might infect cells within breast milk.
In the present study, we examined a number of cross-sectional breast-milk samples obtained from infected mothers
within the first 6 months after delivery, but we failed to detect
2268 • JID 2004:189 (15 June) • Brayfield et al.

HHV-8 DNA at limits of detection of 1 HHV-8 copy/10 4 cells.
Spiking experiments performed in donor breast milk suggest
that HHV-8–infected cells can be readily detected in breast milk,
if present. In the present study, failure to detect HHV-8 could
have been the result of there being too few cells present in our
specimen to allow for sufficient detection of cell-associated
HHV-8 DNA, as has been suggested for CMV [13]; however,
a subset of 9 b-globin–positive breast-milk samples contained
a mean of 14,725 cellular equivalents, as determined by realtime PCR analysis. This indicated that sufficient numbers of
cells and target DNA were present in the breast-milk samples,
unless the number of infected cells present was below the limit
of detection of our assays. In support of this concept, we detected very weak HHV-8 nested PCR signals in a few breastmilk specimens, but such detection was inconsistent and could
not be confirmed using a second set of primers. It is also
possible that, by first collecting samples at 2 months, we missed
the peak level for the detection of viral DNA in breast milk.
To exclude this possibility, we examined colostrum obtained
from 2 HHV-8–seropositive mothers. Colostrum is known to
contain the highest number of cells during lactation. Despite
the high number of cellular DNA equivalents in the colostrum
samples, both of the samples were PCR negative for HHV-8.
There is an additional possibility that breast milk, which contains several potential antiviral components (immunoglobulin,
lactoferrin, vitamin A, lipids, and prostaglandins), could eliminate free virus or virus-infected cells from breast milk [37].
Nevertheless, our results suggest that HHV-8–infected cells may
only rarely, if ever, be present in the breast tissue and milk,
and that breast milk is not a likely route of transmission of
HHV-8 to infants.
Despite the failure to detect HHV-8 in breast-milk samples,
EBV and HIV-1 DNA were readily detected in the same samples
analyzed for HHV-8. These results are similar to those of previous studies of EBV and HIV-1 in breast milk, which reported
prevalences of 46% for EBV and 56%–78% for HIV-1 [28, 38].
Of interest, the presence of EBV DNA in breast milk at the
time of testing was dependent on the mother being infected
with HIV-1 at the time of delivery. The significance of HIV-1
infection of the mother, with regard to the presence of EBV
DNA in breast milk, needs to be investigated further.
We hypothesized that maternal saliva could be an important
mediator of transmission because HHV-8 is not present in
detectable quantities in breast milk and infection appears to
occur early in life by means other than in utero or intrapartum
means. HHV-8 is frequently detected in samples obtained from
the oral cavity, regardless of the population from which they
are obtained; this finding suggests that HHV-8 could be transmitted via saliva [35, 39–41]. Indeed, horizontal transmission
has been suggested previously among men who have sex with
men (MSM) and within families. It is known that HIV-1–

coinfected individuals and patients with KS all have elevated
levels of HHV-8 in the oral cavity, compared with levels of
HHV-8 in the PBMCs, plasma, semen, and skin; this suggests
that the oral cavity may be a site of active viral reactivation
and replication [10, 35, 40]. Cook et al. [42] reported that
HHV-8 DNA was more frequently detected in saliva than in
PBMCs of family members of a patient with KS. Moreover,
that similar viral sequences were detected in the saliva of some
family members supports the concept of transmission via the
oral cavity.
In the present study, examination of HHV-8–infected mothers during the first 6 months after delivery of their infants
indicated that 29% of the mothers were positive for HHV-8 in
the cells from their saliva. This finding is in agreement with
previous studies of HIV-1–infected men in the United States
[10, 35]. The HHV-8 serostatus of the infant at 12 months
after delivery was independent of the presence of HHV-8 in
the saliva cells of the mother at a single time point. Three infants
were born to mothers with detectable viral DNA, whereas 11
infants were born to mothers with undetectable viral DNA in
saliva cells at the time of sampling. Unfortunately, none of the
3 mothers with HHV-8–infected children have sufficient material left for quantification of viral copy numbers in saliva cells
by use of real-time PCR, which would allow detection of a
correlation between virus burden and infection of the infants
of these mothers. The lack of a dependent association between
the presence of HHV-8 DNA in the saliva cells of a mother and
the occurrence of HHV-8 infection in her infant is not unexpected. The level of HHV-8 in the oral cavity has been shown
to vary over time in a cohort of MSM in the United States [35].
In fact, testing of available longitudinal samples from the mothers
evaluated in the present study suggests that the presence of HHV8 in saliva is variable between time points. Furthermore, the time
at which saliva from the mothers was obtained for analysis may
not correlate with the time at which transmission of HHV-8 to
their infants occurred. Different sources and routes of infection,
other than mother-to-infant sources and routes (transmitted by
other household members), likely exist in this population, as has
been suggested for similar populations [25, 42]. In a study of
patients with KS, the prevalence of HHV-8 antibodies was higher
among the spouses and children of the patients than among agematched control subjects [42, 43].
Although the presence of HHV-8 in saliva cells was independent of the HIV-1 infection status of the mother, there
appeared to be a higher median number of HHV-8 copies/
10 4 cells in HIV-1–infected mothers versus uninfected mothers.
However, by use of the Wilcoxon rank sum test of medians,
there was no significant difference in the median level of HHV8 copies/10 4 cells between HIV-1–infected mothers and uninfected mothers. Although this finding is surprising, given that
previous studies of HIV-1–infected men and individuals with

KS have observed an elevated level of HHV-8 in HIV-1–infected
men, the lack of a difference observed in the present study is
likely the result of the small number of samples available for
analysis and the fluctuation of the HHV-8 load in saliva with
time. Nevertheless, the present study supports what other studies have suggested for regions where HHV-8 is endemic—
namely, that exposure through infected saliva is likely responsible for the observed age-specific increase in seroprevalence
through adolescence [4, 11].
We report the first postdelivery study of breast milk for the
presence of HHV-8 DNA in a region of Africa where HHV-8
is endemic. Because this study is a cross-sectional analysis of
specimens obtained from individual mothers, rather than a
longitudinal analysis, it is possible that the presence of HHV8 in breast milk at other time points could have been missed.
Nevertheless, the results of the present study suggest that breast
milk does not frequently contain HHV-8 and is not a main
mode of transmission of HHV-8. However, frequent detection
of HHV-8 in saliva suggests that contact with saliva that contains virus may be a prominent mode of transmission of HHV8 to infants and children in regions of endemicity.
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E R R AT U M

In an article in the 15 June 2004 issue of the Journal (Brayfield
BP, Kankasa C, West JT, et al. The distribution of Kaposi’s
sarcoma-associated herpesvirus/human herpesvirus type 8 in
Zambian maternal saliva and breast milk: implications for
transmission. J Infect Dis 2004; 189:2260–70), the “A” and “B”
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subtype designations in figure 3B were mislabeled and reversed.
The subtype “A” in the upper group of sequences in the figure
should be changed to “C,” and the subtype designation “C” in
the lower group of sequences should be changed to “A.” The
authors regret this error.

